Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?
Soleno Therapeutics Ownership Summary
Soleno Therapeutics is owned by 102.52% institutional investors, 1.31% insiders. Fmr is the largest institutional shareholder, holding 10.89% of SLNO shares. Vanguard Health Care Inv is the top mutual fund, with 5.78% of its assets in Soleno Therapeutics shares.
SLNO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Soleno Therapeutics | 102.52% | 1.31% | -3.83% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 5.79M | 10.89% | $193.80M |
| Wellington management group llp | 4.43M | 8.32% | $148.21M |
| Blackrock funding, inc. /de | 3.74M | 7.04% | $125.31M |
| Vanguard group | 3.06M | 5.74% | $141.69M |
| Blackrock | 1.86M | 5.15% | $76.03M |
| State street | 2.68M | 5.04% | $89.75M |
| Avoro capital advisors | 2.30M | 4.33% | $77.00M |
| Nantahala capital management | 1.74M | 3.28% | $58.39M |
| Polar capital | 1.70M | 3.19% | $56.88M |
| Khrom capital management | 1.51M | 2.84% | $50.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 302.48K | 12.45% | $20.45M |
| Tri locum partners lp | 450.58K | 7.00% | $30.46M |
| Khrom capital management | 1.51M | 4.63% | $50.60M |
| Catalio capital management, lp | 577.81K | 4.04% | $19.35M |
| Ghost tree capital | 300.00K | 3.83% | $12.24M |
| Nantahala capital management | 1.74M | 2.15% | $58.39M |
| Kingdon capital management | 575.00K | 2.11% | $19.25M |
| Bioimpact capital | 150.00K | 1.66% | $10.14M |
| Highvista strategies | 165.23K | 1.53% | $5.53M |
| Readystate asset management lp | 952.16K | 1.43% | $31.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 1.86M | 0.00% | 1.54M |
| Khrom capital management | 1.51M | 4.63% | 1.51M |
| Wellington management group llp | 4.43M | 0.03% | 1.10M |
| Vestal point capital, lp | 730.00K | 0.68% | 730.00K |
| Polar capital | 1.70M | 0.20% | 561.93K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 147.84K | 0.00% | -7.03M |
| Price t rowe associates inc /md/ | 1.03M | 0.00% | -2.29M |
| Fmr | 5.79M | 0.01% | -2.29M |
| Adage capital partners gp | 1.40M | 0.15% | -2.17M |
| Point72 asset management | - | - | -916.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Khrom capital management | 1.51M | 4.63% | 1.51M | $50.60M |
| Vestal point capital, lp | 730.00K | 0.68% | 730.00K | $24.44M |
| Kynam capital management, lp | 560.00K | 1.16% | 560.00K | $18.75M |
| Renaissance | 447.30K | 0.02% | 447.30K | $14.98M |
| Vanguard fiduciary trust | 342.76K | 0.00% | 342.76K | $11.48M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Tfc financial management | -1.00 |
| Tortoise investment management | -2.00 |
| Stephens consulting | -3.00 |
| Cornerstone planning group | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 230 | -16.67% | 54,513,217 | -16.03% | 102 | 0.69% | 133 | -16.35% | 67 | -8.22% |
| Dec 31, 2025 | 119 | -57.65% | 15,780,535 | -75.81% | 29 | 0.18% | 75 | -56.90% | 29 | -49.12% |
| Sep 30, 2025 | 103 | -60.08% | 13,634,031 | -75.97% | 27 | 0.21% | 72 | -55.28% | 21 | -60.38% |
| Jun 30, 2025 | 257 | 1.58% | 56,707,474 | 5.32% | 112 | 0.83% | 162 | 14.89% | 51 | -10.53% |
| Mar 31, 2025 | 260 | 35.42% | 54,569,843 | 6.92% | 118 | 0.80% | 145 | 12.40% | 59 | 110.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.01M | 5.78% | 1.03M |
| Strategic Advisers Fidelity US TtlStk | 2.05M | 3.93% | 104.15K |
| State Street® SPDR® S&P® Biotech ETF | 1.67M | 3.20% | -16.50K |
| Polar Capital Biotech S Inc | 1.61M | 3.11% | 1.61M |
| Vanguard Total Stock Mkt Idx Inv | 1.56M | 3.00% | 4.55K |
| T. Rowe Price US All-Cap Opp Eq Comp | 1.32M | 2.56% | -132.50K |
| iShares Russell 2000 ETF | 1.19M | 2.27% | 10.01K |
| Fidelity Advisor Growth Opps M | 1.04M | 2.02% | - |
| Vanguard US Total Market Shares ETF | 913.59K | 1.99% | - |
| Janus Henderson Global Life Sciences D | 987.38K | 1.89% | -2.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $146.10K |
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $65.18K |
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $17.70K |
| Mar 27, 2026 | Huang Michael F. | Sr. VP of Clinical Development | Sell | $127.84K |
| Mar 27, 2026 | Huang Michael F. | Sr. VP of Clinical Development | Sell | $57.05K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 2 |
SLNO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools